✦ LIBER ✦

Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial

✍ Scribed by François Piette, Joël Belmin, Hélène Vincent…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravenous immunoglobulin for treatment

✍ Dodel, Richard; Rominger, Axel; Bartenstein, Peter; Barkhof, Frederik; Blennow, 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 746 KB

Melissa officinalis extract in the treat

✍ Akhondzadeh, S 📂 Article 📅 2003 🏛 BMJ Publishing Group 🌐 English ⚖ 224 KB

Platform Presentation—Dimebon in Mild-to

📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 41 KB

NILVAD: An investigator initiated multi-

✍ Lawlor, Brian; Crawford, Fiona; Rikkert, Marcel Olde; Mullan, Michael; Tsolaki, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Infliximab for Intensification of Primar

✍ Nordeen, Claire 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Safety, efficacy, and biomarker findings

✍ Lars Lannfelt; Kaj Blennow; Henrik Zetterberg; Stellan Batsman; David Ames; John 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 194 KB